Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

cine Drugs 251
Table 20: First-in-Class and Me-too of Cancer Vaccine Drugs in Phase II Clinical Development 252
Table 21: The Competition Through Close Mechanistic Approximation Between Phase II Cancer Vaccine Drugs 254
Table 22: First-in-Class and Me-too of Cancer Vaccine Drugs in Phase I Clinical Development 255
Table 23: The Competition Through Close Mechanistic Approximation Between Phase I Cancer Vaccine Drugs 257
Table 24: First-in-Class and Me-too of Cancer Vaccine Drugs in Preclinical Development 258
Table 25: The Competition Through Close Mechanistic Approximation Between Preclinical Cancer Vaccine Drugs 259
Table 26: Target Strategies of No Data, Suspended or Terminated Cancer Vaccine Drugs 261
Table 27: Finding Competitive Profile for Best-in-Class Consideration 263
Table 28: Overview of Compound Strategy Competition Among Cancer Vaccine Drugs 388
Table 29: Overview of the Competitive Landscape of Small Molecule Based Cancer Vaccine Drugs 390
Table 30: Pursued Target Strategies of Small Molecule Drugs Based Cancer Vaccine Drugs 391
Table 31: Overview of the Competitive Landscape of Peptide Based Cancer Vaccine Drugs 393
Table 32: Competitive Comparison of Target Strategies of Peptide Based Cancer Vaccine Drugs 394
Table 33: Pursued Target Strategies of Peptide Based Cancer Vaccine Drugs 395
Table 34: Overview of the Competitive Landscape of Protein Based Cancer Vaccine Drugs 397
Table 35: Competitive Comparison of Target Strategies of Protein Based Cancer Vaccine Drugs 398
Table 36: Pursued Target Strategies of Protein Based Cancer Vaccine Drugs 398
Table 37: Overview of the Competitive Landscape of Antibody Based Cancer Vaccine Drugs 400
Table 38: Competitive Comparison of Target Strategies of Antibody Based Cancer Vaccine Drugs 401
Table 39: Pursued Target Strategies of Antibody Based Cancer Vaccine Drugs 401
Table 40: Overview of the Competitive Landscape of Nucleic Aci
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , Oct. 31, 2014 Imago ... today announced a $26.5 million Series A financing ... firm founded by a team of accomplished investment ... investors participating in the round include Frazier Healthcare, ... Representatives from Clarus Ventures and Frazier Healthcare will ...
(Date:10/31/2014)... , October 31, 2014 ... Corporation (NASDAQ: CELG ), Bristol-Myers Squibb Co. ... UNH ), Sanofi SA (NYSE: ... members receive these notes ahead of publication. To reserve ... . , ,-- ,Celgene Corporation Research Reports ,On October ...
(Date:10/31/2014)... Calif. , Oct. 31, 2014 ThynkWare ... sclerosis (ALS) patients initiate text and email messages using ... a patent-pending technology invented by ThynkWare,s founder, Duane ... on a smartphone device. This technology allows users to ... only the power of thought. ThynkWare provides ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... that Acetadote® ( acetylcysteine ) Injection, an injectable product ... available in the Australian market. Phebra Pty Ltd., an ... U.S.-based Cumberland Pharmaceuticals to market and distribute the product ...
... Biotechnology Corporation (Nasdaq: GNBT ) ( www.generex.com ) ... reverse stock split proposal put forward at the Annual Meeting ... DO NOT COUNT as votes cast in respect of ... Special Meeting of stockholders scheduled for 10 a.m. EDT on ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 5Generex Provides Clarification for Special Meeting Voting 2Generex Provides Clarification for Special Meeting Voting 3
(Date:10/31/2014)... Rice University researchers have mapped how information flows through ... metastatic. The research reveals a common pattern in the ... form new tumors. Researchers say the commonality may open ... genetic switches that cancer must flip to form both ... of the main players in cancer metastasis. , "Cells ...
(Date:10/31/2014)... The Memory Healer review published by DailyGossip.org reveals ... father suffered from Alzheimer's disease. , In fact, Alexander ... father's disease. His father pointed a gun and shot him ... the author of this method understood that he needed to ... Healer program is based on years of research. The author ...
(Date:10/31/2014)... Oaks, CA (PRWEB) October 31, 2014 ... tummy also has amazing health effects for practitioners. ... created by a Doctor of Science and Movement ... through his dedication to pelvic floor reeducation that ... of urinary incontinence, Diastasis Recti, Prolepses, etc. , ...
(Date:10/31/2014)... 2014 Activz Whole-Food Nutrition ... line offering natural silver healing support† in liquid ... century, silver has been used to support natural healing, ... is the most advanced version available. This latest formula, ... structure that supports the existing healing mechanisms in the ...
(Date:10/31/2014)... apnea may make it hard for you to remember simple ... your house keys, a small study suggests. Tests on ... -- called spatial memory -- was impaired when sleep apnea ... of sleep weren,t affected. REM sleep is the deepest level ... for the first time that sleep apnea, an increasingly common ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2
... Foundation drives initiative for SCID screening, MILWAUKEE, Jan. ... in the nation to screen all newborns for Severe ... SCID is a,genetic disorder that is fatal without early ... life-saving treatment., The Wisconsin Department of Health and ...
... of Cholestech Brings Strong Financial Expertise ... HAYWARD, Calif., Jan. 3 Thermage, Inc.,(Nasdaq: THRM ... aesthetic,industry, today announced the appointment of John F. (Jack) ... CFO of Cholestech,Corporation, succeeds Laureen DeBuono, who resigned from ...
... depression, even though it doesn,t impact on hot flashes, ... is not a cure for hot flashes, but it does ... Pennsylvania study has found. , The researchers had hoped to ... hormone replacement therapy for women suffering from hot flashes, said ...
... Hispanic ethnic groups and others with a family history of ... glaucoma are particularly vulnerable, SAN ... no early symptoms and do not notice as their peripheral,vision diminishes ... million Americans with the disease are unaware of their condition.,January is ...
... Snack Leader Corazonas Foods Debuts Five Great-Tasting Potato, ... ... Less Fat Than Regular Potato Chips, LOS ANGELES, ... snack foods, transforms the all-American,classic potato chip into a ...
... YORK, Jan. 3 WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corporation ... to participate at two upcoming investor conferences:, -- The ... 7:00pm Eastern Time (ET) -- The 18th ... Conference on January 9, 2008 at 1:05pm Eastern Time ...
Cached Medicine News:Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 2Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 3Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 4Health News:Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease' 5Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 2Health News:Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer 3Health News:Exercise Eases Some Menopause Symptoms 2Health News:Exercise Eases Some Menopause Symptoms 3Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 2Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 3Health News:Corazonas Launches First and Only Cholesterol-Reducing Potato Chips 2Health News:WebMD to Present at Upcoming Investor Conferences 2
... of the easiest tests to run on the ... minutes with no hands-on time. Critical care instructions ... child leaving the pediatrician's office and valuable information ... help control the spread of RSV infections. Now ...
... an ultra-high speed, high resolution optical coherence ... imaging and analysis. It is ... Coherence technology just emerging from clinical research ... The ultra-high speed and high resolution features ...
... hCG Combo with Reference Line ... of human chorionic gonadotropin (hCG) ... This test kit is used ... and is intended for professional ...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... customer support. Delivering optimum performance with ... clear choice for medical professionals worldwide. ...
Medicine Products: